SAN FRANCISCO, Feb. 17, 2023 (GLOBE NEWSWIRE) -- #" Featured Image for Upblocks LLC Featured Image for Upblocks LLC
Teva Presents Positive Efficacy and Safety Data of AJOVY® (fremanezumab) for the Prevention of Episodic Migraine in Children and Adolescents from Phase 3 SPACE Trial 4-12-2024, 14:00